SEC Form 4 · accession 0000899243-19-003848
GW PHARMACEUTICALS PLC · GWPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin D. Gover
Officer — Chief Executive Officer · Director
Period of report
Feb 13, 2019
Accepted (ET)
Feb 15, 2019 · 4:31 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001351288
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF2,F3 | Feb 13, 2019 | S | 22,620 | $12.50 | D | 370,445 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 16, 2018.
- F2These ordinary shares are represented by American Depositary Shares of the Issuer ("ADS"). Each ADS represents twelve ordinary shares of the Issuer. The reporting person acquired these shares on December 20, 2018 in connection with an exercise of options that were due to expire on December 24, 2018.
- F3The price reported in Column 4 is price per ordinary share ($150.0 per ADS).